Medications for Opioid Use Disorder- Partnering Addiction Treatment Counselors with Clients and Healthcare Professionals (2 credit hours)

Program Summary:  This course consists of Part 4 of SAMHSA’s TIP 63:  Medications for Opioid Use Disorder Partnering Addiction Treatment Counselors with Clients and Healthcare Professionals.  The course offers guidance for counselors who work with OUD, OUD medications, and recovery oriented treatment.  The course examines the neurobiology of OUD, FDA-approved medications, and the role of counseling.  Treatment with methadone, buprenorphine, and naltrexone is discussed along with benefits, common misconceptions, and concerns.  The course includes guidance for pregnant women and guidance for working with mutual help groups.

This course is recommended for social workers, counselors, and therapists and is appropriate for beginning and intermediate levels of practice.  

“Book  Open the Course Reading Here.

Course Reading:  Tip 63 Medications for Opioid Use Disorder Part 4:  Partnering Addiction Treatment Counselors with Clients and Healthcare Professionals

Publisher:  Substance Abuse and Mental Health Services Administration

Course Objectives:  To enhance professional practice, values, skills, and knowledge by identifying key issues related to working with individuals with OUD.

Learning Objectives:  Describe changes in brain function from repeated drug use.  Describe FDA-approved medications used to treat OUD.  Describe misconceptions about medications for OUD.  Distinguish OUD from physical dependence on opioid medications.  Describe pathways to recovery.

In order to purchase or take this course, you will need to log in. If you do not have an account, you will need to register for a free account.

After you log in, a link will appear here that will allow you to purchase this course.

1: Which of the following is not a Key Message of the reading?
 
 
 
 
2: Using Exhibit 4.1, which key term describes the DSM-5 disorder characterized by loss of control of opioid use, risky opioid use, impaired social functioning, tolerance and withdrawal?
 
 
 
 
3: The sum of the internal and external resources that an individual can draw upon to begin and sustain recovery from SUDs is referred to as ___________.
 
 
 
 
4: Approximately how many Opioid Treatment Programs currently dispense methadone, buprenorphine, or both?
 
 
 
 
5: People with OUD should have access to
 
 
 
 
6: According to the DSM-5, which of the following is not a diagnostic criteria for OUD?
 
 
 
 
 
7: A person can require OUD medication and be physically dependent on it but still be in remission and recovery from OUD.
 
 
8: The __________ patients take medication, the less likely they are to return to opioid use.
 
 
9: Recovery occurs via
 
 
 
 
10: With person-centered care, the amount, duration, and scope of services is determined by
 
 
 
11: A person-centered approach to OUD treatment empowers
 
 
 
12: Counselors can help reluctant family members engage in the client's treatment if
 
 
 
 
13: With repeated opioid use, the amygdala, which is associated with feelings of danger, fear, and anger, becomes
 
 
14: With repeated opioid use, the frontal cortex, which is associated with planning and self-control, becomes
 
 
15: When opioid use stops, brain changes stop.
 
 
16: Which medication used to treat OUD fully activates the opioid receptor?
 
 
 
17: Which OUD medication reduces craving and blocks the euphoric effect of opioids?
 
 
 
 
18: Which of the following does not describe Buprenorphine?
 
 
 
 
19: Methadone is
 
 
20: Which medication reduces opioid craving but not withdrawal?
 
 
 
21: The injected form of Naltrexone lasts for
 
 
 
 
22: People in early methadone treatment are required by federal regulation to visit the OTP ____________________ to take their medication under observation.
 
 
 
 
23: To avoid severe withdrawal, prescribers will ensure that patients are abstinent from opioids at least ___________ days before initiating or resuming naltrexone.
 
 
 
 
24: When obtaining consent from patients allowing communication directly with their providers, the consent must explicitly state that the patient allows the counselor to discuss
 
 
 
 
25: Which is the most secure way to discuss patient cases?
 
 
 
 
26: What is a counselor's most powerful tool for influencing outcomes?
 
 
 
 
27: A person given naloxone to reverse overdose must go to the emergency department, because __________ can start again when naloxone wears off.
 
 
 
 
28: Which of the following organizations consider individuals to be in recovery if they take OUD medication as prescribed?
 
 
 
 
 
 
 
29: When a patient wants to taper medication or stop altogether, the counselor should do all but which one of the following?
 
 
 
30: According to _____________, employers cannot discriminate against patients taking medication for OUD
 
 
 
 
31: It is federally mandated that people who are incarcerated have access to
 
 
 
 
32: Using exhibit 4.14, which is not recommended during pregnancy?
 
 
 
 
33: NA mutual-help programs _____________ the use of OUD medications.
 
 
34: When facilitating groups that include patients taking OUD medication, it is important to
 
 
 
 

In order to purchase or take this course, you will need to log in. If you do not have an account, you will need to register for a free account.

After you log in, a link will appear here that will allow you to purchase this course.

G.M. Rydberg-Cox, MSW, LSCSW is the Continuing Education Director at Free State Social Work and responsible for the development of this course.  She received her Masters of Social Work in 1996 from the Jane Addams School of Social Work at the University of Illinois-Chicago and she has over 20 years of experience.  She has lived and worked as a social worker in Chicago, Boston, and Kansas City. She has practiced for many years in the area of hospital/medical social work.  The reading materials for this course were developed by another organization.


Filed under: Retired